Close

Emergex Vaccines Announces the Successful Coating of its Novel CD8+ T cell Adaptive COVID-19 Vaccine onto Zosano Pharma’s Micro-Needle Patch May 17, 2022 07:00AM
Zosano Pharma Reports Third Quarter 2020 Financial Results Nov 13, 2020 04:05PM
Zosano Pharma (ZSAN) Receives CRL from FDA for Qtrypta Oct 21, 2020 08:31AM
Zosano Pharma Receives Complete Response Letter from FDA for Qtrypta™ Oct 21, 2020 08:30AM
Zosano Pharma (ZSAN) has received discipline review letter from FDA in connection with Qtrypta NDA Sep 30, 2020 05:41PM


Sep 30, 2020 05:40PM Zosano Pharma Receives Preliminary FDA Communication on Qtrypta™ NDA
Aug 7, 2020 06:26AM Zosano Pharma (ZSAN) Announces Partnership Agreement with EVERSANA to Support the Launch and Commercialization of Qtrypta (Earlier)
Aug 6, 2020 05:00PM Zosano Pharma Announces Partnership Agreement with EVERSANA to Support the Launch and Commercialization of Qtrypta™
Apr 23, 2019 09:24AM Pre-Open Stock Movers 04/23: (GNC) (HAS) (TWTR) Higher; (MBRX) (WAT) (HRL) Lower (more...)
Apr 13, 2016 09:48PM INVESTOR NOTICE: Goldberg Law PC Announces an Investigation of Claims Against Zosano Pharma Corporation and Advises Investors With Losses to Contact the Firm
Apr 8, 2016 02:13PM IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces An Investigation of Claims Against Zosano Pharma Corporation And Advises Investors With Losses To Contact The Firm